Figure 4From: Cost-effectiveness analysis of the available pneumococcal conjugated vaccines for children under five years in Colombia Cost-Effectiveness Acceptability curves of PCV13 vs. PCV10 vs. no vaccine to prevent pneumococcal diseases in a cohort of Colombian children, 2014. Back to article page